ATE421326T1 - Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose - Google Patents
Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthroseInfo
- Publication number
- ATE421326T1 ATE421326T1 AT01954083T AT01954083T ATE421326T1 AT E421326 T1 ATE421326 T1 AT E421326T1 AT 01954083 T AT01954083 T AT 01954083T AT 01954083 T AT01954083 T AT 01954083T AT E421326 T1 ATE421326 T1 AT E421326T1
- Authority
- AT
- Austria
- Prior art keywords
- arthrosis
- treatment
- cyclodextrins
- polysulfated
- polysulfated cyclodextrins
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 229940097362 cyclodextrins Drugs 0.000 title abstract 2
- 201000008482 osteoarthritis Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0009272A FR2811572B1 (fr) | 2000-07-17 | 2000-07-17 | Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421326T1 true ATE421326T1 (de) | 2009-02-15 |
Family
ID=8852528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01954083T ATE421326T1 (de) | 2000-07-17 | 2001-07-12 | Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6930098B2 (de) |
| EP (1) | EP1301192B1 (de) |
| JP (1) | JP4960568B2 (de) |
| AT (1) | ATE421326T1 (de) |
| AU (1) | AU2001276437A1 (de) |
| CA (1) | CA2416369C (de) |
| CY (1) | CY1108980T1 (de) |
| DE (1) | DE60137506D1 (de) |
| DK (1) | DK1301192T3 (de) |
| ES (1) | ES2322794T3 (de) |
| FR (1) | FR2811572B1 (de) |
| PT (1) | PT1301192E (de) |
| WO (1) | WO2002005826A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2297516T3 (es) | 2003-12-02 | 2008-05-01 | Universiteit Gent | Uso de alginato polisulfatado en matrices celulares. |
| US8466278B2 (en) * | 2008-09-22 | 2013-06-18 | Arcarios B.V. | Carboxyethylated cyclodextrin polysulfates useful as medicaments |
| KR20120138240A (ko) | 2010-03-24 | 2012-12-24 | 아카리오스 비.브이. | 치환된 시클로덱스트린 유도체 및 이의 제조방법 |
| ITMI20132116A1 (it) | 2013-12-18 | 2015-06-19 | Apharm Srl | Associazione di glicosamminoglicani e ciclodestrine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4258180A (en) * | 1979-11-05 | 1981-03-24 | American Cyanamid Company | C6-Modified cyclodextrin sulfate salts as complement inhibitors |
| US4247535A (en) * | 1979-11-05 | 1981-01-27 | American Cyanamid Company | Modified cyclodextrin sulfate salts as complement inhibitors |
| ES2059571T3 (es) * | 1988-01-19 | 1994-11-16 | Takeda Chemical Industries Ltd | Fumagilina como agente angiostatico. |
| DK0447171T3 (da) * | 1990-03-15 | 1994-12-12 | Tanabe Seiyaku Co | Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf |
| US5100878A (en) * | 1990-05-07 | 1992-03-31 | American Maize-Products Company | Blocking the effect of teratogens on a fetus |
| AU1162592A (en) * | 1991-01-30 | 1992-09-07 | Hoechst Aktiengesellschaft | Low-molecular sulphated poly-beta -2,6-fructofuranosanes and their use in the treatment of degenerative articular ailments |
| CA2124857A1 (en) * | 1991-11-11 | 1993-05-27 | Howard C. Herrmann | Methods of inhibiting restenosis |
| DE69621528T2 (de) * | 1995-02-07 | 2003-01-16 | Shiseido Co. Ltd., Tokio/Tokyo | Anti-inflamatorische agenzien |
| US5843920A (en) * | 1996-09-16 | 1998-12-01 | Biocell Technology, Llc | Anionic saccharides for extraction of anti-angiogenic protein from cartilage |
-
2000
- 2000-07-17 FR FR0009272A patent/FR2811572B1/fr not_active Expired - Fee Related
-
2001
- 2001-07-12 AU AU2001276437A patent/AU2001276437A1/en not_active Abandoned
- 2001-07-12 WO PCT/FR2001/002253 patent/WO2002005826A1/fr not_active Ceased
- 2001-07-12 JP JP2002511758A patent/JP4960568B2/ja not_active Expired - Fee Related
- 2001-07-12 EP EP01954083A patent/EP1301192B1/de not_active Expired - Lifetime
- 2001-07-12 AT AT01954083T patent/ATE421326T1/de active
- 2001-07-12 ES ES01954083T patent/ES2322794T3/es not_active Expired - Lifetime
- 2001-07-12 CA CA002416369A patent/CA2416369C/fr not_active Expired - Fee Related
- 2001-07-12 PT PT01954083T patent/PT1301192E/pt unknown
- 2001-07-12 US US10/333,226 patent/US6930098B2/en not_active Expired - Fee Related
- 2001-07-12 DK DK01954083T patent/DK1301192T3/da active
- 2001-07-12 DE DE60137506T patent/DE60137506D1/de not_active Expired - Lifetime
-
2009
- 2009-04-14 CY CY20091100441T patent/CY1108980T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20030109493A1 (en) | 2003-06-12 |
| US6930098B2 (en) | 2005-08-16 |
| EP1301192B1 (de) | 2009-01-21 |
| DE60137506D1 (de) | 2009-03-12 |
| JP4960568B2 (ja) | 2012-06-27 |
| JP2004503594A (ja) | 2004-02-05 |
| CA2416369C (fr) | 2008-07-15 |
| FR2811572A1 (fr) | 2002-01-18 |
| CA2416369A1 (fr) | 2002-01-24 |
| WO2002005826A1 (fr) | 2002-01-24 |
| DK1301192T3 (da) | 2009-05-18 |
| ES2322794T3 (es) | 2009-06-29 |
| FR2811572B1 (fr) | 2003-04-18 |
| AU2001276437A1 (en) | 2002-01-30 |
| EP1301192A1 (de) | 2003-04-16 |
| CY1108980T1 (el) | 2014-07-02 |
| PT1301192E (pt) | 2009-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE296094T1 (de) | Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen | |
| DE69936102D1 (de) | Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden | |
| ATE376835T1 (de) | Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| MEP36908A (en) | omega-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS | |
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| ATE273690T1 (de) | Zusammensetzung zur hautdesinfizierung | |
| ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
| ATE301995T1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| DE602004017871D1 (de) | Zubereitungen zur behandlung von arthritischen erscheinungen | |
| DE602004017326D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| DE602004028574D1 (de) | Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie | |
| EE200100125A (et) | TAN-1057 derivaadid | |
| CY1108980T1 (el) | Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
| DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
| DE60013326D1 (de) | Verbindungen und verfahren zur behandlung von schmerz | |
| ATE361071T1 (de) | Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie | |
| ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
| ATE274044T1 (de) | Zusammensetzungen zur behandlung von gewebe | |
| DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1301192 Country of ref document: EP |